QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
Free Trial

RVL Pharmaceuticals (RVLP) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free RVLP Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RVLP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RVLP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

RVL Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.13)($0.13)($0.13) 
Q2 20241($0.10)($0.10)($0.10) 
Q3 20241($0.08)($0.08)($0.08) 
Q4 20241($0.10)($0.10)($0.10) 
FY 20244($0.41)($0.41) ($0.41)

RVLP Earnings Date and Information

RVL Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

RVL Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)		------- 
8/14/2023Q2 2023($0.13)($0.13)-($0.02)$10.38 million$8.26 million
5/11/2023Q1 2023($0.12)($0.12)-($0.12)$9.30 million$8.83 million
3/20/2023Q4 2022($0.15)($0.18)($0.03)($0.18)$12.10 million$9.81 million    
11/10/2022Q3 2022($0.19)($0.16)+$0.03($0.16)$10.05 million$10.02 million
8/11/2022Q2 2022($0.24)($0.19)+$0.05($0.24)$8.40 million$8.45 million
5/12/2022Q1 2022($0.25)($0.13)+$0.12($0.18)$7.20 million$21.44 million
3/30/2022Q4 2021($0.29)($0.26)+$0.03($0.28)$3.10 million$2.86 million    
11/15/2021Q3 2021($0.36)($0.42)($0.06)($0.56)$2.39 million$2.20 million
8/16/2021Q2 2021($0.15)($0.15)-($0.02)$34.50 million$11.51 million
5/13/2021Q1 2021($0.23)($0.15)+$0.08($0.15)$32.00 million$23.88 million

RVL Pharmaceuticals Earnings - Frequently Asked Questions

When is RVL Pharmaceuticals's earnings date?

RVL Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on RVLP's earnings history.

How much revenue does RVL Pharmaceuticals generate each year?

RVL Pharmaceuticals (NASDAQ:RVLP) has a recorded annual revenue of $49.72 million.

How much profit does RVL Pharmaceuticals generate each year?

RVL Pharmaceuticals (NASDAQ:RVLP) has a recorded net income of -$51.69 million. RVLP has generated -$0.70 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:RVLP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
1970’s computer coder issues shocking A.I. warning
TradeSmith